首页 > 市场调查报告书 > 医疗设备

伤口护理

市场调查报告书

商品编码

1603420

黏合剂屏障市场规模、份额、成长分析、按产品、按应用、按配方、按地区 - 行业预测，2024-2031 年

Adhesion Barrier Market Size, Share, Growth Analysis, By Product (Synthetic, Natural), By Application (Gynecological Surgeries, Cardiovascular Surgeries), By Formulation (Film, Liquid) By Region - Industry Forecast 2024-2031

出版日期: 2024年11月27日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球黏合阻隔市场规模将达到6.4亿美元，从2023年的6.8亿美元成长到2031年的11.5亿美元，预计在预测期间（2024-2031年）将成长。为0.68%）。

由于手术数量的增加、运动相关伤害的增加以及全球医疗保健支出的增加，全球黏合屏障市场预计将显着增长。整形外科和心血管手术对黏合屏障的需求特别高，反映出外科手术的激增。在美国，骑自行车和休閒运动等活动会导致严重伤害，进一步增加了对手术解决方案的需求。新兴国家医疗保健的快速进步，加上人口成长和可支配收入的增加，预计将推动市场扩张。然而，这个市场面临着诸如外科手术成本高、黏合屏障的潜在副作用以及阻碍创新和广泛采用的严格法规结构等挑战。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按公司分公司分類的股份分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Baxter International Inc.（United States）
Anika Therapeutics, Inc.（United States）
Sanofi SA（France）
Medtronic plc（Ireland）
Integra LifeSciences Corporation（United States）
Atrium Medical Corporation（Getinge AB）（United States）
FzioMed, Inc.（United States）
MAST Biosurgery AG（Switzerland）
Terumo Corporation（Japan）
Johnson & Johnson（United States）
Becton, Dickinson and Company（United States）
B. Braun Melsungen AG（Germany）
Ferring Pharmaceuticals（Switzerland）
Adhesion Barrier Company（United States）
Fidia Farmaceutici SpA（Italy）
Innocoll Holdings PLC（Ireland）
Biom'Up SAS（Zimmer Biomet Holdings, Inc.）（France）
Aziyo Biologics, Inc.（United States）

结论和建议

简介目录

Product Code: SQMIG15B2076

Global Adhesion Barrier Market size was valued at USD 0.64 billion in 2022 and is poised to grow from USD 0.68 billion in 2023 to USD 1.15 billion by 2031, growing at a CAGR of 0.68% during the forecast period (2024-2031).

The global Adhesion Barrier Market is poised for significant growth, driven by the rising number of surgeries, increasing sports-related injuries, and growing healthcare expenditure worldwide. The demand for adhesion barriers is particularly high in orthopedic and cardiac procedures, reflecting the surge in surgical interventions. In the United States, activities like cycling and recreational sports result in substantial injuries, further fueling the need for surgical solutions. Rapid healthcare advancements in developing countries, coupled with population growth and increased disposable incomes, are expected to enhance market expansion. However, the market faces challenges, including the high cost of surgical procedures, potential side effects of adhesion barriers, and stringent regulatory frameworks that hinder technological innovation and broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adhesion Barrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adhesion Barrier Market Segmental Analysis

Global Adhesion Barrier Market is segmented by Product, Application, Formulation and region. Based on Product, the market is segmented into Synthetic Adhesion Barriers, (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers) and Natural Adhesion Barriers (Collagen and Fibrin)), Based on Application, the market is segmented into General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, and Others. Based on Formulation, the market is segmented into Film, Liquid, and Gel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Adhesion Barrier Market

The global adhesion barrier market is driven by the rising number of surgical procedures across various domains, including general/abdominal, gynecological, cardiovascular, orthopedic, and neurological surgeries. This growing surgical volume escalates the need for effective adhesion barriers to minimize postoperative complications and adhesion formation. Additionally, heightened awareness among healthcare professionals and patients about the severe consequences of adhesions-such as pain, bowel obstruction, infertility, and organ dysfunction-further boosts demand. Technological advancements in adhesion barrier formulations, including synthetic solutions offering enhanced efficacy, biocompatibility, and extended durability, also play a crucial role in market expansion. These innovations not only improve surgical outcomes but also encourage the adoption of adhesion barriers, solidifying their importance in modern medical practices.

Restraints in the Global Adhesion Barrier Market

A significant restraint for the global adhesion barrier market is the high cost associated with these products, which limits their adoption, particularly in price-sensitive regions. Adhesion barriers, often used in surgical procedures to prevent post-operative adhesions, can significantly increase overall treatment costs, making them less accessible for patients and healthcare facilities with constrained budgets. Additionally, the stringent regulatory approval processes for medical devices in various regions can delay market entry for new adhesion barrier products, further hindering growth. Limited awareness among healthcare professionals and patients regarding the long-term benefits of adhesion barriers also contributes to lower adoption rates, particularly in emerging markets. This creates challenges for manufacturers to achieve widespread penetration and expand their market share globally.

Market Trends of the Global Adhesion Barrier Market

The global Adhesion Barrier Market is witnessing transformative trends driving its growth. A notable development is the rising adoption of bioresorbable adhesion barriers, which naturally degrade and are absorbed by the body, eliminating the need for additional surgical removal. This trend aligns with the growing demand for solutions that minimize complications and enhance patient recovery. Additionally, the market is experiencing a surge in product innovation, with companies investing heavily in research and development. These efforts focus on creating advanced adhesion barrier formulations that offer superior biocompatibility, extended efficacy, and improved usability. Together, these trends underscore the market's dynamic nature and its commitment to delivering cutting-edge solutions to meet the evolving needs of healthcare professionals and patients.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
- PESTEL Analysis
Market Attractiveness Index
Pricing Analysis

Global Adhesion Barrier Market Size by Product & CAGR (2024-2031)

Market Overview
Synthetic Adhesion Barriers
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Other
Natural Adhesion Barriers
- Collagen
- Fibrin

Global Adhesion Barrier Market Size by Application & CAGR (2024-2031)

Market Overview
General/Abdominal Surgeries
Gynecological Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Neurological Surgeries
Other

Global Adhesion Barrier Market Size by Formulation & CAGR (2024-2031)

Market Overview
Film
Liquid
Gel

Global Adhesion Barrier Market Size & CAGR (2024-2031)

North America, (Product, Application, Formulation)
- US
- Canada
Europe, (Product, Application, Formulation)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Application, Formulation)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Application, Formulation)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Application, Formulation)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atrium Medical Corporation (Getinge AB) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FzioMed, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MAST Biosurgery AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adhesion Barrier Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fidia Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innocoll Holdings PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biom'Up SAS (Zimmer Biomet Holdings, Inc.) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aziyo Biologics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments